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Abstract 
 
 In metastatic brain lesions treatment, stereotac-
tic radiation therapy represents a valid alternative to 
surgery, which indication is limited to single lesions, 
in accessible brain sites and in patients presenting an 
optimal performance status. 
The aim of this study was to develop a novel 
method for delivering fractionated stereotactic in-
tensity-modulated radiotherapy. We present treat-
ment parameters, dosimetry analysis, and prelimi-
nary clinical outcome. The method incorporates 
high-precision invasive fixation and reduced dimen-
sion pencil beams. 
In our hospital, since January 2008  Hypofraction-
ated Stereotactic Radiation Therapy is performed 
using Serial Tomotherapy with Nomostat® System, 
connected to a 6 MV Linac. This system realizes an 
IMRT with dynamic gantry and a beam modulation 
by a binary multileaf collimator (MIMiC® multi-
vane intensity-modulating collimator) attached to 
the Linac head. During gantry rotation, collimator 
automatically modifies its morphology following 
target shape. In treatment of lesion smaller than 
1,5cm, a post-collimation device called Beak® pro-
vides leaves opening limitation to 4mm, allowing 
an high dose conformation around the target and an 
high dose fall-off in surrounding healthy tissues.  
For stereotactic radiation therapy in brain malignan-
cies, we use Talon® immobilization device, a mini-
mally invasive system which consists in two tita-
nium screws fixed in patient scalp; this device, 
making the patient in solidarity with the couch, pro-
vides high accuracy in his positioning during radio-
therapy sessions. 
In our experience, the technique has proven to be 
easy in implementation and highly reliable, allow-
ing accurate repositioning in the hypofractionated 
treatments. 
  
 
INTRODUCTION 
 
Radiation therapy consists in therapeutic use of ion-
izing radiation in malignant disease. High radiation 
doses arise probability of disease care, but also tox-
icity, so treatment plans derive always from a com-
promise between curative and toxic doses.  
Advanced radiation therapy techniques are required 
to allow delivering of higher and potentially cura-
tive doses to treatment volumes, respecting toler-
ance doses of organ at risk near the target.  
Radiation therapy needs several steps: patient set-up 
definition, imaging acquisition for treatment plan-
ning (TC without contrast enhancement), contour-
ing volumes of interest on TC slices (Planning Tar-
get Volume, Organs At Risk), also with imagine 
fusion between TC and contrasted TC or RM, treat-
ment planning and, finally, treatment sessions.  
Three-dimensional conformal radiation therapy 
(3DCRT) is the standard technique and consists in 
using multiple fields conformed on target geometry 
and dose contribution fixed for every beam. Treat-
ment planning is defined forward planning because 
the operator provides beam modelling on PTV and 
OAR shape and prescription to a point dose 
(isocenter). 
Intensity Modulated Radiation Therapy (IMRT) is 
an advanced technique which allows  a conformal 
beam geometry and a fluence modulation of radia-
tion beam geometric and dosimetric parameters 
(modulation of beam shape and intensity). The 
treatment plan is obtained with an inverse planning, 
because the operator defines PTV and OAR con-
straints and beam fluence optimization is automati-
cally calculated by treatment planning system (TPS) 
(Fig. 1).  
Stereotactic radiosurgery was introduced more than 
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50 years ago as a way of treating various intracranial 
lesions without recourse to open-skull surgery. Since 
then, it has been extended both in terms of the radia-
tion modalities that have been used and the types of 
lesions treated [1]. Stereotactic radiation therapy con-
sists in the application of very high ionizing radiation 
doses in larger than conventional fractionation (2 Gy/
die) to  volumes smaller than conventional radiother-
apy fields often with integration of advanced modali-
ties for tumour imaging and devices for patient im-
mobilization [2]. In particular, in stereotactic therapy 
of intracranial lesions, is mandatory to use bloody 
immobilization devices, such as Leksell helmet (Fig. 
2).  
It consists in four screws fixed to patient scalp and a 
ring fixed to the helmet. This device is useful only in 
single fraction stereotactic radiotherapy, because of 
its uncomfortableness. 
The aim of this paper is to describe a cranial stereo-
tactic radiation therapy technique using Serial Tomo-
herapy and Talon immobilization device as alterna-
tive to Leksell stereotactic helmet. The design of the 
system is intended to combine the accuracy of an 
invasive system while supporting  fractionated 
stereotactic treatment regimens. 
 
MATERIALS AND METHODS  
 
The sequential tomotherapy system 
Serial Tomotherapy (Nomostat® System) [3] is an 
advanced IMRT system which uses a standard linear 
accelerator (Linac) combined with several tools that 
allows a dynamic arc intensity modulation radiother-
apy [4]. This system consists of an inverse planning 
system and multileaf collimator, that is attached to 
the Linac head and operates dynamically during an 
arc delivery. In short, by segmenting target treatment 
into sections, or slices, dose to each slice can be tai-
lored to match target shape on that slice, thus leading 
to a truly 3D conformal distribution. 
Nomostat® System consists in three units: MIMiC®, 
Autocrane® and Corvus®. 
The MIMiC® (Multileaf  Intensity-Modulatin Colli-
mator) consists of two rows of 20 leaves governed by 
a binary system (open or close) and moved by a 
pneumatic mechanism. Collimator shape changes 
following target morphology every 5° along a gantry 
rotation of 340°, defining a pencil beam, so also 2560 
pencil beam for an arch can be delivered. MIMiC® 
can be used in three modalities, in according to three 
different levels of leaves opening: 2cm , 1cm and 
beak (4mm). 
Autocrane®, attached to the couch top hand rails, is 
useful system for precision indexing of the table. It is 
needful in case of target length superior to leaves 
maximum opening (maximum beam length: nominal 
4cm, real 3.2cm). In facts, it provides to automatic 
couch movement at the end of an arch delivering to 
the next treatment slice. To limit slice-to-slice do-
simetric  junctioning errors to 5%, couch incrementa-
tion has to be accurate to about 0.2mm  
Corvus® is an inverse planning system that provides 
to automatic calculation of dose distribution, in re-
spect to target prescription and constraints to organ at 
risk near the target.  
Serial Tomotherapy allows IMRT and Stereotactic 
treatments.  
Talon® is a removable stereotactic head fixation and 
positioning device, characterized by accuracy of an 
invasive system while supporting fractionated stereo-
tactic treatment regimens. It requires neurosurgical 
bicortical insertion of two self-tapping titanium base 
screws into patient‟s skull (20 min, local anesthesia). 
For imaging and treatment, Talon is attached to base 
screws. 
The assembly has adjustable locking ball joints and 
extension rods to allow for minute adjustment of cra-
nium position. The variability of possible fixation 
positions allows for patient comfort while rigidly im-
Beam 1 
Beam 3 
Beam 2 
Prescription dose 
distribution 
Fig.1: Differences between forward planning and invers 
planning. Beam fluente modulation allows concave dose 
distribution, which in not achievable with 3DCRT. 
a b c 
Fig 2: Leksell helmet: to align precisely the and the posi-
tioning of the isocentric site of linear accelerator. 
D. Russo, A. Papaleo, A. Leone, M.G. Natali, G. Pastore, M. Santantonio  
 36 
 
 
mobilizing the patient‟s head. Once all the degrees of 
freedom of the Talon® device are tightened and, 
thereby, locked into a patient-specific position, the 
device remains unaltered for all subsequent imaging 
and treatment of the patient. The particular Talon® 
device used belongs to that patient for the entire 
course of treatment and specifically defines the pa-
tient‟s treatment position. The Talon® assembly and 
patient were subsequently attached to the Nomogrip, 
a rigid perpendicular extension to the radiotherapy 
treatment table. Essentially, the Talon® system uses a 
one-time invasive placement of two titanium base 
screws combined with a non-invasive daily applica-
tion of talon device to facilitate a removable stereo-
tactic immobilization and alignment system (Fig.3) 
[5]. 
To treat smaller intracranial lesions, Nomostat® Sys-
tem includes beak (Fig.4), a post-collimation attach-
ment to MIMiC® that allows the target to be seg-
mented into even more and even thinner treatment 
slices, limiting the leaves‟ opening lenght to 4mm, 
resulting in significant improvements in dose confor-
mity and reduction of inferior/superior spillover of 
dose [3,8]. 
 
 
Patient and tumor characteristics 
In our hospital, from January 2009 to May 2010, 36 
patients (17 male and 19 female; median age 61 
years; range 34-84 years) with 1-4 brain metastatic 
lesions (Ǿ max 3-4cm) underwent to Intensity Modu-
lated Hypofractionated Stereotactic treatment  using 
Serial Tomotherapy and Talon immobilization de-
vice. The total number of irradiated lesions is 63 
(Table 1). In every patient, a pre-treatment brain RM 
was performed. Post-radiation therapy RM was per-
formed after 3 and 6 months. 
 
Treatment planning and delivery 
CT images of the patient immobilized in the treat-
ment position were acquired using the TALON sys-
tem. 
Image acquisition was performed on a Siemens Emo-
cion 6 (Siemens Medical Solutions) in 3-mm con-
tiguous slices, covering the entire patient head, from 
the base of skull upward. The thinner section CT 
slices were acquired to cover the target region and 
the stereotactic localizer. 
MR imaging was performed without the TALON at-
tached, because the metallic composite would have 
caused major image distortion. Typically, T1- and T2
- weighted MR images, as well as T1 post-contrast 
images, were acquired in contiguous slices using a 
512x512 image matrix. 
CT and MRI data sets were imported into a comput-
erized intensity-modulated treatment planning pro-
gram (Corvus 3, Nomos Corp.). Image registration/
fusion for CT and MRI was based on anatomical 
landmark registration. 
The target was delineated as planning target volume 
(PTV) that encompassed the gross tumor volume (as 
identified in CT and MRI contrast-enhanced imag-
Fig. 3.: a) Talon system: a unit with 2 head screws for pre-
cise localization.  It is less invasive than competing tech-
nology.  b, c) Talon® and titanium screws inserted in pa-
tient scalp. 
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Fig. 4:  Beak: a post-collimation 
device that was inserted into the 
opening of the MlMiC for fine detail 
stereotactic IMRS delivery with a 
beamlet size of 4x8mm.  
Table 1: Stratification of patients treated in our institu-
tion on basis of primary tumours generating brain metas-
tasis  
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ing) and a safety margin of 2 mm. In addition, the 
brain stem, optic chiasm, optic nerves, and the eyes 
were delineated. 
For the present treatment plans, the goal was always 
30 Gy in 5 daily fractions. Every treatment started on 
Monday and ended on Friday. Plan  
optimization was performed to obtain that 100% of 
tumor volume receive at least 95% of prescription 
dose and hot spots of 150% of dose within the target 
were accepted.   
Patients received IMRT treatment using one couch 
angle (0 degrees) and the rotational arc ranged from 
215° to 145° (290 arcing degrees). 
The dose-volume histogram (DVH)-driven objective 
function of the planning system computed an opti-
mized dose distribution (Fig. 6). An example of dose 
distribution in axial, coronal and sagittal plan is 
shown in fig. 6A. A representation of treatment view 
is shown in fig. 6B. An example of stereotactic treat-
ment DVH is shown in  Fig. 5. 
Treatment was delivered using a 6-MV linear accel-
erator (Primus, Siemens) and the attached MlMiC 
binary collimator (Nomos Corp.). The pencil-beam 
size for the 1-cm mode was automatically delivered 
by the MlMiC and the BEAK post-collimation device 
was inserted into the opening of the MlMiC. The pa-
tients were precisely repositioned on the treatment 
couch using the TALON system. The target isocenter 
was adjusted according to stereotactic coordinates 
calculated during treatment planning. Duration of a 
typical treatment was 20 to 25 minutes, requiring 1 or 
2 serial arcs. Daily set-up control was performed us-
ing a portal imaging system. 
 
Pretreatment patient quality assurance 
Stereotacic Radiotherpy requires a dedicates quality 
assurance (QA) procedure for each treatment patient. 
The aim of patient QA is to check the agreement be-
tween the dose distribution calculated by the TPS and 
the effective one.  
In our hospital, patient specific Stereotacic Ra-
diotherpy  treatment plan QA is based on a so-called 
hybrid plan verification, i.e. an accepted treatment 
plan is recalculated with unmodified fluence maps in 
a verification phantom. The resulting dose distribu-
tion of such a composite treatment plan is measured 
with film and compared to the calculated one. The 
phantom consists of plates which allow inserting 
films in axial planes. The dimensions of the phantom 
is 17cm x17cmx18cm high. Additionally, a dedicated 
 
Fig. 6. : a) Treatment plan view in a 3D reconstruction of contoured structures. b, c): dose distribution around brain le-
sions: axial and coronal dose distribution for three small intracranical lesions, with a display of the planning target volume 
(red, violet and yellow) and the brain stem (blue). The 100% isodose line (pink) as well as the 90% (red), 80% (orange), 
50% (green) and 10% (blue) isodose lines are displayed. The dose-surface rendering displays that the entire target volume 
is covered by the 100% isodose, while only a small surface fraction of the brain stem is exposed to potentially clinically 
relevant doses (50%). d) The DVH documents 99% targets volume coverage by the prescription isodose and excellent 
dose sparing regarding the healthy tissue 
a b 
c 
d 
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ionization chamber insert is an integral part of the 
respective phantom, which can be filled with pure 
polystyrene if film measurements are carried out. 
For film measurements EDR-2 film (Eastman Kodak 
Company, New York, US) is used in a plane as it al-
lows verifying a typical daily fraction dose of 2 Gy. 
The film is processed using a computer controlled 
film processor (KodakM35 X-Omat processor). After 
processing, the film is scanned with a Vidar VXR-12 
plus scanner (Vidar Systems Corp, Herndon, VA) 
connected to a PC. All scans are performed with a 
resolution of 300 dpi. Film analysis is performed us-
ing OmniPro- I‟mRT software package. After select-
ing a region of interest and using a low pass filter for 
noise reduction purposes, the resolution is reduced to 
1 mm. A 1 mm grid size is also used to compute dose 
distributions with the TPS. For the conversion of op-
tical density to dose a so-called normalized sensi-
tometric curve is used [ 10]. With this method a rela-
tive dose distribution can be obtained. 
For absolute dosimetry ionization chamber measure-
ments are performed in regions of shallow dose gra-
dient using a calibrated cylindrical ionization cham-
ber (Room Exradin A1, volume sensitive: 0,0056 
cm3) connected to an appropriate electrometer (type 
NE 2620, Nuclear Enterprise). 
The two dose distributions, calculated and measured, 
are evaluated by γ method [11-14]. This concept 
combines a dose difference criterion with a distance-
to-agreement (DTA) criterion for each point of inter-
est. For the present work, all γ vector calculations are 
based on 3% dose criteria and 3 mm DTA acceptance 
criteria, where the 3% dose deviation is relative to the 
dose at the normalization point (Fig. 8).  
 
 
RESULTS  
 
Re-position accuracy was high in every patient and in 
every radiation fraction. Median set-up error was 
1mm (range 0-2). On post-treatment RM, tumour re-
sponse was classified as complete response (RC) 
when a reduction of tumour volume was at least 75% 
was observed, partial response (RP) if reduction was 
between 50 % and 75%, stable disease (SD) if tumour 
reduction was less than 50% and progression of dis-
ease for arising tumour volume. 
The results in our series are shown in Table 2. After 
three months from treatment, we observed a complete 
or partial response in 69% of cases. 
 
 
DISCUSSION 
 
Stereotactic treatment are delivered in single fraction 
because of uncomfortable bloody immobilization sys-
tem such as Leksell helmet. It allows high accurancy 
in patient positioning, lesion treatment and OARs 
sparing, considering the complex interplay between 
time-dose-fractionation, partial volume effect, physi-
cal dose distribution, and set-up uncertainties in influ-
encing treatment outcome. The radiobiological ad-
vantage of dose-fractionation for normal tissue spar-
ing is estimated using the linear-quadratic model and 
Fig.7: The treatment plan slice to be validated with film 
dosimetry as used in the initial quantitative quality assu-
rance system. a) The film from the isocentric plane in TPS 
modelling. b)The film from the phantom . c) the line dose 
profile obtained from planned dose data  (red line) and 
from measured data (green line) d)  index method to 
check the agreement between the dose distribution calcu-
lated by the TPS and the effective one: blue color repre-
sents regions where the gamma index criterion is complied 
with and red for the other regions where the gamma index 
criterion fails. 
a c 
b d 
Response N° of lesions 
RC 30 
RP 14 
SD 16 
PD 3 
Total irradiated lesions 63 
 
Table 2: description of tumor response 3 months after 
treatment.  
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viewed in the context of clinical situations and re-
sults. 
Instead, multiple fraction treatment is characterized 
by larger geometrical uncertainty which would re-
quire increased treatment volume and an associated 
decrease in treatment dose [6]. 
An evaluation of Talon® repositioning accuracy, us-
ing a system based on sets of anatomic landmarks 
coordinates, evaluated in repeated CT scans,  con-
cluded that the device is very well suited for immobi-
lization and alignment of single-fraction stereotactic 
radiosurgical applications.  
Furthermore, the unique removable design of the sys-
tem was also seen to facilitate the use of the device 
for extremely accurate and reproducible alignment of 
the patient for fractionated stereotactic treatment 
courses. The excellent accuracy of the system for sin-
gle-fraction applications was seen to deteriorate only 
slightly over a 6-week course of treatment, so  Talon®  
repositioning accuracy is greatest in hypofractionated 
treatment. Lastly, the removable design of the system 
was also seen to make possible the separation of the 
image acquisition, treatment planning, and treatment 
phases of the process into separate days, an option 
seen as desirable by our radiosurgery team [5]. Frac-
tionation of dose is an important principle of radia-
tion therapy. It allows dose escalation to tumour vol-
ume, because after every fraction healthy tissue can 
repair lethal and sublethal DNA  risk. Using Nomo-
stat® System, patient is positioned in an alignment 
point automatically derived from Talon position and 
Autocrane® provide to automatic movement of the 
couch, with an accuracy of 0,2mm, reducing risk of 
positioning errors. Furthermore, using multiple iso-
centers in treatment of multiple brain lesions, can 
produce dose overlap in several regions. Inverse plan-
ning allows dose prescription to a reference isodose 
and exclude risk of overlapping dose in healthy brain. 
In practise, IMRT treatment planning improves Con-
formity Index (CI: ratio of tissue volume covered by 
the prescribed dose to the target volume).  Homoge-
neity Index (HI: ratio of the maximum isodose within 
PTV to the reference isodose ) depends on isocenters 
number. IMRT allows high dose homogeneity within 
the target also in irregularly shaped lesions, while 
disomogeneity grade in radiosurgery is higher than 
30%. This date is proportional to late toxicity.In re-
garding to OARs sparing, radiosurgery seems to pro-
vide to a better Brainstem sparing than IMRT, but 
IMRT improves OAR sparing in large and irregular 
target. Tissue around target receives minor doses us-
ing radiosurgery with circular collimators, so ra-
diosurgery seems to be better in single fraction treat-
ments. However, results show that IMRT treatment 
modality produces similar results as radiosurgery for 
small, spherical lesions, whereas it is found to be su-
perior to SRS for irregular lesions in terms of critical 
structure sparing and better dose homogeneity [7]. 
The use of Beak® in lesions smaller than 1,5cm, fur-
ther improves conformation of dose around the target. 
A study comparing dose distribution using Beak® or 
1cm- MIMiC® collimator, demonstrate that Beak® 
allows better CI without homogeneity reduction and 
better dose fall-off in the healthy tissues around the 
target. This advantage is superior in small lesions, in 
irregularly shaped lesions and in high dose fractions. 
The Authors concluded that Beak stereotactic radia-
tion therapy can be considered as an alternative to 
gamma Knife [8]. 
Another important advantage of IMRS (Intensity 
Modulated RadioSurgery) is the possibility to per-
form a set-up control throughout portal image acqui-
sition on Linac, which are confronted with DRR de-
riving from TC slice, allowing a safe patient reposi-
tioning during every radiation fraction. 
 
 
CONCLUSIONS 
In our experience, the use of Serial Tomotherapy in 
the treatment of brain malignancies demonstrates  
easy implementation and high accuracy. The reposi-
tioning, checked daily through the portal images, was 
safe. This is also demonstrated by the high percentage 
of radiation necrosis found in the brain lesions sites at 
RM after at least 6 months. 
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